Paul Saladino· MD
for the first few weeks they found a dip in the diversity and then it came back and it went higher than baseline
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
for the first few weeks they found a dip in the diversity and then it came back and it went higher than baseline
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and the other fascinating thing was a um a 2018 study published in um frontiers of microbiology called reduced mass and diversity of the clonic microbiome in patients with multiple sclerosis and their improvement with a ketogenic diet and that one is really cool because what they found they followed people with a ketogenic diet